Major Growth Driver Identified in 2025 Biopsy Devices Market: Rising Cancer Incidence Drives Robust Growth In The Biopsy Devices Market

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

Biopsy Devices Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
The biopsy devices market has experienced robust growth in the past few years. It is projected to increase from $3.03 billion in 2024 to $3.24 billion in 2025, with a compound annual growth rate (CAGR) of 6.9%. This expansion during the historical period can be traced back to the growth in emerging markets, the advancement of healthcare frameworks, and the rise in the aging population.

Biopsy Devices Market Size Forecast: What's the Projected Valuation by 2029?
In the coming years, the biopsy devices market is predicted to enjoy robust expansion. The market is projected to reach a volume of $4.56 billion in 2029, experiencing a 9.0% compound annual growth rate (CAGR). Factors such as increasing healthcare expenditure, a surge in cancer incidences, and governmental investments into healthcare have been cited as major drivers for this growth. Additionally, various trends in the sector, including product innovation, technological progress, the inception of fully automated biopsy systems, the rise of robot-assisted biopsy systems, along with growing partnerships, collaborations, and heightened investment are also expected to boost the market during the forecast period.

View the full report here:
https://www.thebusinessresearchcompany.com/report/biopsy-devices-global-market-report

What Are the Drivers Transforming the Biopsy Devices Market?
The biopsy devices market has seen growth due to an increase in the number of cancer occurrences. Biopsies are commonly used by medical professionals as an initial method to diagnose potential cancerous irregularities in the body. For example, the American Cancer Society, a nationwide voluntary health organization headquartered in the US with a mission to eradicate cancer, predicted in January 2023 that the US will likely diagnose about 1.9 million new cancer cases in 2022 and project approximately 609,360 cancer-related fatalities. Specifically, around 151,030 new instances of colorectal cancer are anticipated to be detected by the end of 2022, potentially leading to roughly 52,550 fatalities in 2023. Moreover, the Canadian Medical Association Journal, a peer-reviewed open-access general medical journal based in Canada and published by the Canadian Medical Association, reported in May 2022 that roughly 233,900 new cancer diagnoses are expected in Canada in 2022. Of these, around 28,600 are projected to be breast cancer, which will account for about 25% of all new cancer diagnoses in women that year. The highest expected cancer type for 2022 in Canada is lung cancer, with a projected 30,000 new cases.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=3283&type=smp

What Are the Key Trends Driving Biopsy Devices Market Growth?
The market for biopsy devices is being molded by the introduction and utilization of robot-assisted biopsy systems, designed to minimize complications resulting from the process. These robot-assisted procedures aim to enhance the precision of biopsies, and regulatory bodies are endorsing these devices to simplify the process. For example, Siemens Healthineers and Intuitive received FDA approval in July 2022 for their collaborative robotic-assisted platform developed specifically for minimally invasive lung biopsies, incorporating 2D and 3D imaging capabilities during the procedure.

Which Segments in the Biopsy Devices Market Offer the Most Profit Potential?
The biopsy devices market covered in this report is segmented -

1) By Product Type: Needle-Based Biopsy Guns, Biopsy Forceps, Biopsy Guidance Systems, Biopsy Needles, Other Products
2) By Image Guiding Technology: MRI-Guided Biopsy, Stereotactic-Guided Biopsy, Ultrasound-Guided Biopsy, Other Imaging Technologies
3) By Application: Breast Biopsy, Gynecological Biopsy, Prostate Biopsy, Blood Cancers Biopsy, Skin Biopsy, Kidney Biopsy, Gastroenterology Biopsy, Other Applications
4) By End User: Diagnostics And Imaging Centers, Hospitals, Other End User

Subsegments:
1) By Needle-Based Biopsy Guns: Spring-Loaded Biopsy Guns, Vacuum-Assisted Biopsy Guns
2) By Biopsy Forceps: Endoscopic Biopsy Forceps, Surgical Biopsy Forceps
3) By Biopsy Guidance Systems: Ultrasound-Guided Biopsy Systems, CT-Guided Biopsy Systems, MRI-Guided Biopsy Systems
4) By Biopsy Needles: Core Needles, Fine Needle Aspiration (FNA) Needles, Coaxial Needles
5) By Other Products: Biopsy Sutures, Biopsy Markers, Biopsy Storage Solutions

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=3283&type=smp

Which Firms Dominate the Biopsy Devices Market by Market Share and Revenue in 2025?
Major companies operating in the biopsy devices market include Becton Dickinson and Company (BD), Hologic, Inc., Danaher Corporation, Boston Scientific Corporation, Olympus Corporation, Cook Medical, Medtronic Inc, Cardinal Health, Argon Medical Devices Inc., Fujifilm Holdings Corp, BMA Co. Ltd., Transmed (China) Co., LTD, HaploX Biotechnology, Gene+sLab, Lepu Medical Technology, CMR Naviscan Corporation, DDD Diagnostics, Philips Healthcare, Siemens Healthineers, Abbott Laboratories, Bangs Laboratories Inc, Roche Diagnostics, Cepheid, Devicor Medical Products, Braile Biomedica Ltd, B.Braun Medical Gulf, Stryker ESCS BV

Which Regions Offer the Highest Growth Potential in the Biopsy Devices Market?
North America was the largest region in the biopsy devices market in 2024. Asia-Pacific was the second largest region in the global biopsy devices market report share. The regions covered in the biopsy devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=3283

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Saumya Sahey
Europe: +44 7882 955267,
Asia: +44 7882 955267 & +91 8897263534,
Americas: +1 310-496-7795
Email: saumyas@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.